Dr. Cindy Ivanhoe, MD
Physical Medicine & Rehabilitation (PM&R) (Physical Medicine & Rehabilitation Physician)
- Medicare participating
At a glance
- Years since graduation
- 42
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 84
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Physical Medicine & Rehabilitation Physician primary
TX license F2616
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Physical Medicine & Rehabilitation (PM&R) per capita by county →
Where they work
Hospitals
- Memorial Hermann Hospital System Houston, TX
- Memorial Hermann - Texas Medical Center Houston, TX
Medical groups
- Ut Physicians (1,765 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 84
- Services billed
- 348
- Patients’ average age
- 64
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 40-54 minutes | 34 | 26 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | 31 | 20 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 31 | 14 |
| Established patient office or other outpatient visit, 30-39 minutes | 28 | 22 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | 24 | 14 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 24 | 17 |
| Established patient office or other outpatient visit, 20-29 minutes | 22 | 15 |
| Injection of chemical for paralysis of nerve muscles on arm or leg, 1-4 muscles, each additional extremity | 14 | 11 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Donepezil Hcl Other prescribers in Houston, TX | 20 |
| Duloxetine Hcl Other prescribers in Houston, TX | 15 |
| Gabapentin Other prescribers in Houston, TX | 14 |
| Escitalopram Oxalate Other prescribers in Houston, TX | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 8 companies reported 34 payments worth $11,988 in total to this clinician.
| Ipsen Biopharmaceuticals, Inc | $6,723 |
|---|---|
| AbbVie Inc. | $4,634 |
| Medtronic, Inc. | $262 |
| Pacira Pharmaceuticals Incorporated | $118 |
| Globus Medical, Inc. | $105 |
| Boston Scientific Corporation | $91.97 |
| Revance Therapeutics, Inc. | $37.85 |
| Merz Pharmaceuticals, LLC | $16.33 |
| Compensation for services other than consulting (speaking, faculty) | $5,625 |
|---|---|
| Consulting Fee | $4,150 |
| Food and Beverage | $2,184 |
| Travel and Lodging | $28.46 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc Jun 2, 2025 | Compensation for services other than consulting (speaking, faculty) Dysport · Neurology | $5,625 |
| AbbVie Inc. Jun 26, 2025 | Consulting Fee BOTOX · FACIAL AESTHETICS | $3,325 |
| AbbVie Inc. Jan 9, 2025 | Consulting Fee | $825 |
| AbbVie Inc. Jun 26, 2025 | Travel and Lodging BOTOX · FACIAL AESTHETICS · travel to PHOENIX, AZ · in-kind | $28.46 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $29,749 in research payments for these studies, mostly to the institutions running them.
- A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity.
Ipsen Pharma Sas · Completed · NCT04936542
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.